Cargando…

Tazemetostat: EZH2 Inhibitor

Epigenetic regulation is a novel approach to cancer treatment. Inhibition of enhancer of zeste homolog 2 (EZH2) is a method to provide targeted epigenetic regulation. Tazemetostat is a first-in-class targeted epigenetic regulator that specifically inhibits EZH2. This new FDA-approved oral treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Straining, Rachael, Eighmy, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955562/
https://www.ncbi.nlm.nih.gov/pubmed/35369397
http://dx.doi.org/10.6004/jadpro.2022.13.2.7